Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine, clofarabine, and busulfan before stem cell transplant for CLL
NCT01629511Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 2012
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in chronic lymphocytic leukemia (CLL), prolymphocytic leukemia (PLL), Richter syndrome (RS), sponsored by University of Texas MD Anderson Cancer Center. Started Nov 2012; status: terminated.
02
Drugs
gemcitabine
03
Conditions
chronic lymphocytic leukemia (CLL)prolymphocytic leukemia (PLL)Richter syndrome (RS)
Beyond the preview
Go deeper on NCT01629511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01629511.